Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2003
10/23/2003WO2003086287A2 Compounds and methods for inducing apoptosis in proliferating cells
10/23/2003WO2003086283A2 Metastasis modulating activity of highly sulfated oligosaccharides
10/23/2003WO2003086282A2 Nitric oxide donors, compositions and methods of use
10/23/2003WO2003086280A2 Immunostimulatory g,u-containing oligoribonucleotides
10/23/2003WO2003086279A2 Inhibitors of akt activity
10/23/2003WO2003086267A2 Multi-phase, multi-compartment capsular system
10/23/2003WO2003086254A1 Oxygen enriched implant for orthopedic wounds
10/23/2003WO2003086175A2 Compositions and methods for the therapy and diagnosis of lung cancer
10/23/2003WO2003086108A1 Hydrothermically processed compositions containing phytosterols
10/23/2003WO2003086107A1 Method for obtaining a physiological tannin extract from banana trees and the use thereof as food complement
10/23/2003WO2003086100A1 Dietary methods for canine performance enhancement
10/23/2003WO2003086080A1 Method and composition for improving fertility health in female and male animals and humans
10/23/2003WO2003086078A1 Method of reducing calcified arterial plaque buildup and cellular malfunction and for balancing ionic calcium
10/23/2003WO2003086075A1 Parasite control in animals
10/23/2003WO2003086074A1 Method for treating hepatic encephalopathies
10/23/2003WO2003068929A9 Methods of inhibiting hiv-1 vpr activity and hiv-1 infectivity using atr or rad17 inhibitors
10/23/2003WO2003063776A3 Methods and compositions for treating male erectile dysfunction
10/23/2003WO2003059343A3 Drug compositions with indole alkaloids for the treatment of aids
10/23/2003WO2003057898A3 Methods and materials for modulating p2x2
10/23/2003WO2003057252A8 Human mast cell-expressed membrane proteins
10/23/2003WO2003057147A3 Useful aroyl pyrrole heteroaryl methanones and methanols
10/23/2003WO2003055848A3 Urea derivatives as vr1- antagonists
10/23/2003WO2003053343A3 Novel compounds that enhance dimerization of the subunits of hiv-1 reverse transcriptase having mutations associated with resistance to nonnucleoside reverse transcriptase inhibitors
10/23/2003WO2003053325A3 Microencapsulation of drugs by solvent exchange
10/23/2003WO2003051315A3 Heteroaryl substituted triazole modulators of metabotropic glutamate receptor-5
10/23/2003WO2003051124A3 Inhibition of the asexual reproduction of fungi
10/23/2003WO2003048773A3 Methods for monitoring amyotrophic lateral sclerosis
10/23/2003WO2003047518A3 Cyclodextrin grafted biocompatible amphiphilic polymer and methods of preparation and use thereof
10/23/2003WO2003045523A3 Therapeutic coating for an intravascular implant
10/23/2003WO2003043966A3 Clusianon isomers and use thereof
10/23/2003WO2003039473A3 Method for treating or preventing inflammatory diseases
10/23/2003WO2003039468A3 Antimnemonic therapy for hypermemory syndromes
10/23/2003WO2003039352A3 Methods of reversing and preventing cardiovascular pathologies
10/23/2003WO2003037323A3 Inhibitors of the fatty acid oxidation for prophylaxis and treatment of diseases related to mitochondrial dysfunction
10/23/2003WO2003035047A3 Combinations comprising a selective cyclooxygenase-2 inhibitor
10/23/2003WO2003032902A3 Tumor targeted photodiagnostic-phototherapeutic agents
10/23/2003WO2003027094A3 Substituted 3-pyridyl indoles and indazoles as c17,20 lyase inhibitors
10/23/2003WO2003020279A3 Compositions and methods of treatment of cancer
10/23/2003WO2003017824A3 Method and apparatus for acne treatment
10/23/2003WO2003016469A3 Chemo-enzymatic synthesis of sialylated oligosaccharides
10/23/2003WO2003014307A3 Antisense modulation of apolipoprotein(a) expression
10/23/2003WO2003008576A3 Synthetic double stranded oligonucleotides for targeted inhibition of gene expression
10/23/2003WO2003007954A3 Sulfonyl aryl hydroxamates and their use as matrix metalloprotease inhibitors
10/23/2003WO2003005954A3 Methods and materials for the treatment of testosterone deficiency in men
10/23/2003WO2003002064A3 Fused pyrimidine dhfr inhibitors as antibacterials
10/23/2003WO2003000922A3 Chimeric immunomodulatory compounds and methods of using the same
10/23/2003WO2003000226A3 Pharmaceutical compositions containing polymer and drug assemblies
10/23/2003WO2002099099A3 Polymorphisms in the human gene for cytochrome p450 polypeptide 2c8 and their use in diagnostic and therapeutic applications
10/23/2003WO2002094248A3 Composition and use of substances for stabilising amino acids containing sulphur and/or for inhibiting the continuous formation of amino acids containing sulphur in a blood sample
10/23/2003WO2002092056A8 Compaction process for manufacture of sodium phenytoin dosage form
10/23/2003WO2002092015A3 Reagents and methods for modulating dkk-mediated interactions
10/23/2003WO2002081518A3 Proteins, polynucleotides encoding them and methods of using the same
10/23/2003WO2002074034A3 Novel medicament compositions based on anticholinergic agents and endothelin antagonists
10/23/2003WO2002070556A9 POLYPEPTIDE OF A P53 PROTEIN-SPECIFIC MURINE Α/β T-CELL RECEPTOR, NUCLEIC ACIDS CODING THEREFOR AND USE THEREOF
10/23/2003WO2002067688A8 Noninvasive measurements of chemical substances
10/23/2003WO2002060535A8 Method of treating inflammatory conditions by inhibiting cytosolic phospholipase a¿2?
10/23/2003WO2002055700A3 Human genes and gene expression products isolated from human prostate
10/23/2003WO2002044321A3 Rna interference mediating small rna molecules
10/23/2003WO2002042465A8 Production of stilbenes in transgenic plants and the method of producing thereof
10/23/2003WO2002042272A8 Substituted polycyclic aryl and heteroaryl pyridines useful for selective inhibition of the coagulation cascade
10/23/2003WO2001047562A8 Hydrolytically degradable carbamate derivatives of poly(ethylene glycol)
10/23/2003WO2001045641A8 Inhibitors of thrombin induced platelet aggregation
10/23/2003WO2001041754A8 Inhibitors of collagen-induced platelet aggregation
10/23/2003WO2001041751A8 Phytoestrogens for treating als
10/23/2003WO2001039765A8 Compositions and methods for the induction and treatment of retinal detachments
10/23/2003WO2001036048A8 Phorboxazole derivatives for treating cancer
10/23/2003WO2001015680A8 Composition for treatment of infections of humans and animals
10/23/2003WO2001009328A8 15571, a novel gpcr-like molecule of the secretin-like family and uses thereof
10/23/2003WO2001005427A8 Psca: prostate stem cell antigen and uses thereof
10/23/2003US20030199728 Agent for enhancing alpha-wave appearance, an agent for inducing a relaxed state and a food or drink comprising the agent
10/23/2003US20030199712 Hydrolysis and halogenation of ester of 2-substitued imino-3-methyloxo-butyric acid by photochemical irradiation in one pot using a halogenting agent to form 4-halogeno-2-substituted imino-3-oxo-butyric acid
10/23/2003US20030199701 Treating under hydrolyzing conditions a hydantoin compound to form an alpha-amino acid derivative
10/23/2003US20030199698 Anticoagulants such as 2'-tert-butylaminosulfonylbiphenyl-4-yl-(3-(5-methyl-1,2,4-oxadiazol-3 -yl)benzyl)(2-cyanoethyl) carbamate, used for prophylaxis of cardiovascular disorders
10/23/2003US20030199697 Method for the treatment of malaria by the use of primaquine derivative n1-(3-ethylidinotetrahydrofuran-2-one) -n 4-(6-methoxy-8-quinolinyl)-1,4-pentanediamine as gametocytocidal agent
10/23/2003US20030199694 Thermally stable trimetrexates and processes for producing the same
10/23/2003US20030199693 Theophylline and 3-isobutyl-1-methylxanthine based N-7 substituted derivatives displaying inhibitory activies on PDE-5 phosphodiesterase
10/23/2003US20030199691 2-(2,6-dichlorophenyl)-diarylimidazoles
10/23/2003US20030199689 Heterocyclic nitrogen compounds such as 1-(5-(5-Chlorothiophen -2-yl)-isoxazol-3-ylmethyl)-1H-indole-2-carboxylic acid (1-isopropyl-piperidin-4-yl)-amide, used as anticoagulants for prophylaxis of cardiovascular disorders
10/23/2003US20030199674 Used as pharmaceuticals, diagnostics, biosensors and bioreactors
10/23/2003US20030199592 Method for treating Crohn's Disease
10/23/2003US20030199591 Novel carbamide peroxide compositions for the treatment of dermatological disorders and methods for their use
10/23/2003US20030199590 Prostaglandin analogues for promotion of hair growth
10/23/2003US20030199589 Anticonvulsant and central nervous system-depressing bis (fluorophenyl) alkylamides and their uses
10/23/2003US20030199588 Levothyroxine compositions and methods
10/23/2003US20030199587 For immediate release; thyroid hormone drugs
10/23/2003US20030199586 Comprises crosslinked sodium carboxymethylcellulose; hormone replacement therapy
10/23/2003US20030199585 Immediate release thyroid hormone drugs; sugar-free
10/23/2003US20030199582 Tolterodine salts
10/23/2003US20030199581 Enriched compositions compared to commercial extracts have enhanced biological activity toward variety of proliferative and/or inflammatory afflictions in mammalian hosts and demonstrate synergism with other phytochemicals
10/23/2003US20030199580 Condensation of amine derivative with carboxylic acid derivatives to afford intermediate compound, followed by cyclization of intermediate compound in presence of acid; hyopoglycemic action
10/23/2003US20030199576 Stabilized pure vitamin C in powder-to-liquid form using multi-encapsulation method
10/23/2003US20030199575 P-hydroxyphenyl propionic acid derivatives as antiproliferative agents
10/23/2003US20030199574 May be delivered by intravitreal injection such that the compound causes vitreal liquefaction, posterior vitreoretinal detachment and other affects
10/23/2003US20030199573 2h-chromene derivatives metabolized both by cytochrome P450 and by a non-oxidative metabolic enzyme or system of enzymes; do not cause metabolic DDI when co-administered with other drugs
10/23/2003US20030199571 Useful in treatment and prophylaxis of conditions mediated by s-CD23 or tumor necrosis factor; autoimmune disease, inflammation, allergy
10/23/2003US20030199570 Phenyl substituted thiophenes as estrogenic agents
10/23/2003US20030199569 Pyrrolidine derivatives
10/23/2003US20030199568 Salt of perindopril and pharmaceutical compositions containing it
10/23/2003US20030199567 Combinations of an alpha-2-delta ligand with a selective inhibitor of cyclooxygenase-2
10/23/2003US20030199565 Gastrin and cholecystokinin receptor ligands(II)
1 ... 5299 5300 5301 5302 5303 5304 5305 5306 5307 5308 5309 5310 5311 5312 5313 5314 5315 5316 5317 5318 5319 ... 7860